Melanotan II 10 mg

Manufacturer: Hilma Biocare, Europe

Pharmaceutical name: Melanotan II

Pack: 1 vial (10 mg)

Melanotan II was initially created as a possible preventative measure against different types of skin cancer. The idea was that by artificially triggering the body's tanning mechanism in individuals at high risk for skin cancer due to sun exposure, it could potentially reduce their chances of developing the illness later in life.

 

In addition to offering a tan without the need for prolonged sun exposure and potentially enhancing sexual performance and/or libido, Melanotan II may also aid in appetite reduction by targeting a receptor in the brain responsible for appetite suppression. While this effect is not overpowering, it is noticeable to most users and is considered beneficial by many. The duration of the tanning effect after a user stops applying the drug will depend on various factors; however, most users generally observe that the tan attained with the product fades and becomes imperceptible within four to eight weeks after discontinuing its use.

 

For the majority of users, during the loading phase with the hormone, a dosage range of 0.015 to 0.02 milligrams per kilogram of body weight per injection should be adequate. These injections can be administered anywhere from twice a day to as rarely as once every other day or even longer. During the maintenance phase, many users find that a dose of about 0.01 milligrams per kilogram of body weight given once every few days is sufficient to sustain the hormone's effects.